Karp JE - Search Results

1

Targeting the process of farynesylation for therapy of hematologic malignancies.

Karp JE, Lancet JE. Karp JE, et al. Curr Mol Med. 2005 Nov;5(7):643-52. doi: 10.2174/156652405774641052. Curr Mol Med. 2005. PMID: 16305490 Review.

2

The expanding challenge of HIV-associated malignancies.

Broder S, Karp JE. Broder S, et al. Among authors: karp je. CA Cancer J Clin. 1992 Mar-Apr;42(2):69-73. doi: 10.3322/canjclin.42.2.69. CA Cancer J Clin. 1992. PMID: 1311619 Review. No abstract available.

3

Management of infectious complications of acute leukemia and antileukemia therapy.

Karp JE, Merz WG, Dick JD, Saral R, Burke PJ. Karp JE, et al. Oncology (Williston Park). 1990 Jul;4(7):45-53; discussion 53-4. Oncology (Williston Park). 1990. PMID: 2143941 Review.

4

Cure of acute myelocytic leukemia in adults: a reality.

Geller RB, Saral R, Karp JE, Santos GW, Burke PJ. Geller RB, et al. Among authors: karp je. Leukemia. 1990 May;4(5):313-5. Leukemia. 1990. PMID: 2201825 Review.

5

A two-step timed sequential treatment for acute myelocytic leukemia.

Geller RB, Burke PJ, Karp JE, Humphrey RL, Braine HG, Tucker RW, Fox MG, Zahurak M, Morrell L, Hall KL, et al. Geller RB, et al. Among authors: karp je. Blood. 1989 Oct;74(5):1499-506. Blood. 1989. PMID: 2676014 Clinical Trial.

6

Secondary acute myelocytic leukemia after adjuvant therapy for early-stage breast carcinoma. A new complication of cyclophosphamide, methotrexate, and 5-fluorouracil therapy.

Geller RB, Boone LB, Karp JE, Davidson N, Selonick SE, Edwards J, Burke PJ. Geller RB, et al. Among authors: karp je. Cancer. 1989 Aug 1;64(3):629-34. doi: 10.1002/1097-0142(19890801)64:3<629::aid-cncr2820640311>3.0.co;2-l. Cancer. 1989. PMID: 2743258

7

An approach to intensive antileukemia therapy in patients with previous invasive aspergillosis.

Karp JE, Burch PA, Merz WG. Karp JE, et al. Am J Med. 1988 Aug;85(2):203-6. doi: 10.1016/s0002-9343(88)80343-7. Am J Med. 1988. PMID: 3165248

8

Syndrome of idiopathic hyperammonemia after high-dose chemotherapy: review of nine cases.

Mitchell RB, Wagner JE, Karp JE, Watson AJ, Brusilow SW, Przepiorka D, Storb R, Santos GW, Burke PJ, Saral R. Mitchell RB, et al. Among authors: karp je. Am J Med. 1988 Nov;85(5):662-7. doi: 10.1016/s0002-9343(88)80239-0. Am J Med. 1988. PMID: 3189370

9

Molecular foundations of cancer: new targets for intervention.

Karp JE, Broder S. Karp JE, et al. Nat Med. 1995 Apr;1(4):309-20. doi: 10.1038/nm0495-309. Nat Med. 1995. PMID: 7585060 Review.

10

Molecular pathogenesis and targets for therapy in myelodysplastic syndrome (MDS) and MDS-related leukemias.

Karp JE. Karp JE. Curr Opin Oncol. 1998 Jan;10(1):3-9. doi: 10.1097/00001622-199801000-00002. Curr Opin Oncol. 1998. PMID: 9466478 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results